氯乙基亚硝基脲

Chloroethylnitrosourea is a potent alkylating agent used in chemotherapy.
克氯乙基硝基脲是一种强效烷化剂，用于化疗。
The drug's effectiveness against glioblastoma multiforme relies on its chloroethylnitrosourea component.
这种药物对多形性胶质母细胞瘤的有效性依赖于其氯乙基硝基脲成分。
Chemotherapy protocols often incorporate chloroethylnitrosourea to treat brain tumors.
化疗方案通常会包含氯乙基硝基脲来治疗脑肿瘤。
The side effects of chloroethylnitrosourea can include nausea and hair loss.
氯乙基硝基脲的副作用可能包括恶心和脱发。
Preparations of chloroethylnitrosourea are administered intravenously for targeted therapy.
氯乙基硝基脲制剂通过静脉注射进行靶向治疗。
Researchers are exploring the possibility of modifying chloroethylnitrosourea to minimize its toxic effects.
研究人员正在研究修改氯乙基硝基脲以减少其毒性影响的可能性。
The drug's synthesis involves a reaction between nitrous acid and chloroethylene.
制备这种药物涉及硝酸与氯乙烯的反应。
Chloroethylnitrosourea is a cornerstone of radiation oncology for treating head and neck cancers.
对头颈部癌症的放射治疗中，氯乙基硝基脲起着基石作用。
The drug's half-life in the bloodstream determines the frequency of dosing for chloroethylnitrosourea treatments.
氯乙基硝基脲在血液中的半衰期决定了治疗的给药频率。
Long-term survivors of chloroethylnitrosourea treatment often experience late effects, such as cognitive decline.
接受氯乙基硝基脲治疗的长期存活者常会出现后遗症，如认知能力下降。